Free Trial

ASP Isotopes (NASDAQ:ASPI) Trading 11% Higher - Time to Buy?

ASP Isotopes logo with Basic Materials background

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shot up 11% during mid-day trading on Thursday . The company traded as high as $7.70 and last traded at $7.76. 2,326,433 shares changed hands during trading, a decline of 19% from the average session volume of 2,884,223 shares. The stock had previously closed at $6.99.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lifted their price target on ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a report on Wednesday, May 21st.

Read Our Latest Report on ASPI

ASP Isotopes Price Performance

The company has a current ratio of 7.21, a quick ratio of 7.17 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $608.76 million, a PE ratio of -11.84 and a beta of 3.35. The company has a fifty day moving average price of $7.43 and a two-hundred day moving average price of $5.87.

Insider Activity

In other news, COO Robert Ainscow sold 66,668 shares of the business's stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $374,674.16. Following the completion of the sale, the chief operating officer directly owned 1,419,992 shares of the company's stock, valued at approximately $7,980,355.04. The trade was a 4.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Paul Elliot Mann sold 316,666 shares of the business's stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $1,779,662.92. Following the completion of the sale, the chief executive officer directly owned 7,315,454 shares of the company's stock, valued at $41,112,851.48. The trade was a 4.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 766,667 shares of company stock valued at $4,358,502 over the last three months. Company insiders own 21.40% of the company's stock.

Institutional Trading of ASP Isotopes

Several institutional investors and hedge funds have recently made changes to their positions in ASPI. BNP Paribas Financial Markets purchased a new stake in ASP Isotopes during the 4th quarter valued at approximately $34,000. SBI Securities Co. Ltd. raised its stake in ASP Isotopes by 84.8% during the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after acquiring an additional 4,299 shares during the last quarter. Avantax Advisory Services Inc. purchased a new stake in ASP Isotopes during the 4th quarter valued at approximately $45,000. Russell Investments Group Ltd. raised its stake in ASP Isotopes by 56.3% during the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock valued at $46,000 after acquiring an additional 3,682 shares during the last quarter. Finally, Covestor Ltd purchased a new stake in ASP Isotopes during the 4th quarter valued at approximately $54,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Recommended Stories

Should You Invest $1,000 in ASP Isotopes Right Now?

Before you consider ASP Isotopes, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.

While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines